Portfolio Companies in the News

» 23/12/05
SpineVision® reports a market penetration milestone: 1000th spine surgery performed using Company’s PediGuard™ device, world

» 14/12/05
Professor Peter Van Brummelen and DR. Annick Schwebig join the board of directors of Diatos S.A.

» 13/12/05
Corevalve sucessfully inititates first North American clinical trial, using its novel revalving™ system at Montreal Heart Institute to non-surgically replace diseaded aortic heart valve of 64-year-old female patient not eligiblefor open-heart surgery

» 13/12/05
CoTherix and Respironics Announce Launch of New Portable Inhalation Device to Ventavis Patients

» 06/12/05
SpineVision® raises $16+ million and spins out its New Technologies Uni to form FlexSpine in Singapore, which will focus on developing motion preservation solutions for spinal surgery

» 22/11/05
Tsinghua Tongfang and 6Wind partnership to take China's booming ICT market by storm

» 21/11/05
Howard Ford former Managing Director of Equant joins Varioptic as Chairman of the Board Lyon, France

» 17/11/05
6Wind contributes to success of KDDI's mobile broadband project

» 15/11/05
Grenoble, France, 15 November 2005: VoluBill, a leading provider of Data and Content charging solutions for mobile Operators (GPRS, EDGE, 3G, WiFi), has appointed John Aalbers as CEO, effective from the beginning of January 2006.

» 14/11/05
Boehringer Ingelheim and Biolipox sign agreement on a new class of drugs to treat pain and inflammation

» 10/11/05
Esmertec China developed and delivered exclusive testing platform to China Mobile Communications Corporation

» 07/11/05
Fovea Pharmaceuticals completes a €20.5 million ( million) Series A financing to develop new drugs for retinal diseases.

» 25/10/05
SpineVision® reports U.S. market penetration milestone

» 20/10/05
Corevalve's revalving™ system demonstrated 'live' at opening session of TCT 2005 to an audience of 12,000 interventional cardiologists and device industry executives

» 19/10/05
VARIOPTIC’s pilot line automates production Reproducible manufacturing process yields reliable quality lenses

» 23/09/05
Servista wins "BPO Service Provider of the Year" at NOA awards ceremony 2005

» 17/10/05
Corevalve's revalving™ system demonstrated ' live' session of TCT 2005 to an audience of 12, 000 international cardiologists and device industry executives

» 05/10/05
Sofinnova Partners annonces the successful stock market flotations of two portfolio companies

» 03/10/05
Corevalve names Jack Lips as "European clinical manager"

» 30/09/05
VistaPrint Announces Pricing of Initial Public Offering

» 30/09/05
VoluBill announces “Charge it” – a comprehensive mobile data charging solution

» 26/09/05
Addex Pharmaceuticals Initiates Phase I Trials with ADX10059, a novel compound intended for Anxiety and Migraine

» 06/09/05
Varioptic expands its focus to deliver liquid lenses in new markets

» 31/08/05
NEC Infrontia adopts Esmertec’s Java runtime platform, Jbed CDC, as the standard JVM for its terminal devices

» 30/08/05
Cerenis Therapeutics announces license agreement with Nippon Chemiphar to develop new therapies based on PPAR Delta Agonist

» 22/08/05
Cerenis Therapeutics completes €25 million ($ 30.5 million) Series A financing to progress HDL-related drugs for cardiovascular deseases

» 22/08/05
“Bohemian Medical Device Summit 2005” will showcase Ars Arthro AG and CoreValve SA in kick-off panel discussion—“Business Models for European Start-Ups”—to be moderated by two of Europe’s most successful VCs: Sofinnova Partners’ Antoine Papiernik and Heid

» 16/08/05
Epimmune and IDM S.A. Join Forces to become IDM Pharma, Inc.

» 28/07/05
WebSideStory Announces Record Second Quarter 2005 Results

» 25/07/05
UPEK® provides Biometric Finger security for the THINKPAD* Tablet

» 03/08/05
Infraworlds creates SagaZ, a new game format for the mass market

» 28/07/05
InfraWorlds to acquire 995 SOFT and enter the US market

» 26/07/05
Infraworlds receives €3.55 million

» 06/07/05
Esmertec officially opened its R&D and Customer Support Center in Chengdu, China

» 05/07/05
Esmertec decides to postpone its IPO

» 28/06/05
Revolt technology receives €7 million in first round of financing

» 27/06/05
Esmertec and LG Electronics Demonstrate Multi-tasking Java Virtual Machine on a Mobile Handset

» 14/06/05
6WIND reinstates defense roots with strategy and software launch for net-centric warfare communications

» 20/06/05
Sofinnova Partners invests €4 million in Endotis Pharma

» 07/06/05
OXXIUS Shrinks DPSS Lasers and announces world’s smallest blue laser module

» 23/05/05
Cellzome announces exercise of option to Alzheimer’s disease compounds by Ortho-McNeil Pharmaceutical

» 17/05/05
DIATOS S.A. opens its US subsidiary in California – DIATOS USA, INC.

» 17/05/05
DIATOS and SERVIER announce oncology research collaboration using the VECTOCELL® technology

» 16/05/05
New Ventavis(R) Data to Be Presented at American Thoracic Society's International Conference

» 16/05/05
Corevalve reports it has certified its Irvine, Calif., clean room operations to be used in manufacturing company's Revalving™ system for percutaneous aortic valve replacement (PAVR)

» 12/05/05
6WIND announces R&D partnership with China academy of science

» 26/04/05
GPC Biotech and Ingenium Receive € 2.2 Million Joint Drug Discovery Grant from German Ministry

» 14/04/05
Diatos named among the 2005 red herring 100 Europe

» 12/04/05
Diatos S.A. opens its US subsidiary in California - Diatos USA, Inc.

» 12/04/05
Neuro3d Reports Positive Results from Phase II Trials of Ocaperidone in Schizophrenia

» 04/04/05
Two-Month Follow-up of first South-American patient shows 58-year-old female is fully recovered and has resumed normal activity after non-surgical replacement of defective aortic heart valve using Corevalve's breakthrough ReValving™ procedure

» 08/04/05
CoTherix Enters Into Agreement with Quadrant for Development of Extended-Release Formulation of Ventavis

» 06/04/05
Esmertec acquires majority stake in eValley, Japan

» 22/03/05
CoTherix's Ventavis(R) Commercially Available for the Treatment of Pulmonary Arterial Hypertension

» 17/03/05
Epimmune and IDM agree to combine businesse

» 16/03/05
Varioptic to demonstrate the world's first liquid zoom lens for camera phones at Cebit

» 16/03/05
Cellzome Announces Drug Discovery Collaboration in Alzheimer's Disease with Ortho-McNeil Pharmaceutical

» 08/03/05
CoTherix Reports Positive Clinical Data From STEP Study

» 22/02/05
SpineVision® receives FDA clearance for PediGuard™,world’s first and only free-hand drilling instrument able to detect an inadvertent breach in the vertebral pedicle or vertebral body

» 16/02/05
DIATOS N.V.’s oncology research boosted by significant funding

» 08/02/05
WebSideStory Announces Agreement to Acquire Atomz and Launch of Active Marketing Suite

» 08/02/05
XYOTAX Patent Allowance Provides Exclusivity in Europe Until 2017

» 02/02/05
Esmertec Acquires Mobile Division of CoreTek Systems, China

» 28/01/05
Esmertec and MontaVista Software to deliver integrated Java-Linux solutions for mobile phones

» 27/01/05
XYOTAXTM Pivotal Trial in Non-Small Cell Lung Cancer, STELLAR 3, Reaches Required Number of Events

» 27/01/05
Diatos named by Tornado insider amoung europe's Top 100 private tech companies - Best Performing Companies of 2004 -

» 19/01/05
U.S patent & trademark office issues patent no 6,830,584 to CoreValve for its 'device for replacing a cardiac valve by percutaneous route'

» 17/01/05
Addex Pharmaceuticals enters into Collaboration with Ortho-McNeil Pharmaceutical to Develop Novel Treatments for Anxiety, Depression, Schizophrenia and Alzheimer's disease

» 10/01/05
Biolipox successfully completes million financing round – Scandinavian Life Science Venture new investor

» 05/01/05
Diatos acquires oncology product rights from Macromed

» 03/01/05
CoreValve receives German government's approval to initiate clinical trial using its revalving™ system to percutaneously replace diseased aortic heart valves